What does CUSIP 04351P101 represent in this 13F holders report?

CUSIP 04351P101 is the security identifier for ASND - Ascendis Pharma A/S - Common Stock used to aggregate holder disclosures.

How many institutions held ASND - Ascendis Pharma A/S - Common Stock in Q2 2015?

32 institutional investors reported ASND - Ascendis Pharma A/S - Common Stock for Q2 2015. Use the holders table for investor-level position and value details.

Ascendis Pharma A/S - Common Stock (ASND)

CUSIP: 04351P101

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / Common Stock
Shares outstanding: 61,152,075
Total 13F shares: 8,953,630
Share change: +475,596
Total reported value: $157,820,000
Price per share: $17.68
Number of holders: 32
Value change: +$7,731,541
Number of buys: 13
Number of sells: 20

Quarterly Holders Quick Answers

What is CUSIP 04351P101?
CUSIP 04351P101 identifies ASND - Ascendis Pharma A/S - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 04351P101:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ASND - Ascendis Pharma A/S - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
ORBIMED ADVISORS LLC	13F	Company	2.4%	1,448,991	$25,140,000	—	31 Mar 2015	13F
RA CAPITAL MANAGEMENT, L.P.	13F	Company	1.7%	1,023,652	$17,760,000	—	31 Mar 2015	13F
FMR LLC	13F	Company	1.6%	981,300	$17,026,000	—	31 Mar 2015	13F
VHCP Management, LLC	13F	Company	1.3%	811,152	$12,911,000	—	31 Mar 2015	13F
SECTORAL ASSET MANAGEMENT INC	13F	Company	1.2%	731,660	$12,694,000	—	31 Mar 2015	13F
RS INVESTMENT MANAGEMENT CO LLC	13F	Company	1.1%	656,170	$11,385,000	—	31 Mar 2015	13F
PICTET ASSET MANAGEMENT LTD	13F	Company	0.57%	348,668	$5,938,000	—	31 Mar 2015	13F
GREAT POINT PARTNERS LLC	13F	Company	0.56%	339,863	$5,896,000	—	31 Mar 2015	13F
Visium Asset Management, LP	13F	Company	0.45%	275,000	$4,771,000	—	31 Mar 2015	13F
ACUTA CAPITAL PARTNERS, LLC	13F	Company	0.37%	228,612	$3,966,000	—	31 Mar 2015	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.33%	204,825	$3,553,000	—	31 Mar 2015	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.33%	200,000	$3,470,000	—	31 Mar 2015	13F
SABBY MANAGEMENT, LLC	13F	Company	0.32%	194,023	$3,366,000	—	31 Mar 2015	13F
BLACKROCK ADVISORS LLC	13F	Company	0.21%	131,300	$2,278,000	—	31 Mar 2015	13F
SCOPIA CAPITAL MANAGEMENT LP	13F	Company	0.2%	125,000	$2,169,000	—	31 Mar 2015	13F
BAKER BROS. ADVISORS LP	13F	Company	0.16%	100,000	$1,735,000	—	31 Mar 2015	13F
Alyeska Investment Group, L.P.	13F	Company	0.16%	99,955	$1,734,000	—	31 Mar 2015	13F
DAFNA Capital Management LLC	13F	Company	0.15%	93,541	$1,623,000	—	31 Mar 2015	13F
HIGHLAND CAPITAL MANAGEMENT LP	13F	Company	0.14%	87,609	$1,520,000	—	31 Mar 2015	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.11%	70,000	$1,215,000	—	31 Mar 2015	13F
Cormorant Asset Management, LP	13F	Company	0.1%	61,500	$1,067,000	—	31 Mar 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.1%	60,316	$1,046,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.09%	53,121	$922,000	—	31 Mar 2015	13F
Rock Springs Capital Management LP	13F	Company	0.06%	35,540	$617,000	—	31 Mar 2015	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.04%	22,000	$382,000	—	31 Mar 2015	13F
Sterling Capital Management LLC	13F	Company	0.03%	19,452	$337,000	—	31 Mar 2015	13F
PUTNAM INVESTMENTS LLC	13F	Company	0.03%	18,809	$326,000	—	31 Mar 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.03%	16,892	$293,000	—	31 Mar 2015	13F
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)	13F	Company	0.02%	10,228	$177,000	—	31 Mar 2015	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.02%	10,000	$174,000	—	31 Mar 2015	13F
BlackRock Investment Management, LLC	13F	Company	0.01%	8,800	$153,000	—	31 Mar 2015	13F
MORGAN STANLEY	13F	Company	0.01%	5,250	$91,000	—	31 Mar 2015	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	2,575	$45,000	—	31 Mar 2015	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	1,323	$23,000	—	31 Mar 2015	13F
UBS Group AG	13F	Company	0%	865	$15,000	—	31 Mar 2015	13F
CITIGROUP INC	13F	Company	0%	80	$1,000	—	31 Mar 2015	13F

Institutional Holders of Ascendis Pharma A/S - Common Stock (ASND) as of Q2 2015

As of 30 Jun 2015, Ascendis Pharma A/S - Common Stock (ASND) was held by 32 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 8,953,630 shares. The largest 10 holders included RA CAPITAL MANAGEMENT, LLC, ORBIMED ADVISORS LLC, FMR LLC, RS INVESTMENT MANAGEMENT CO LLC, VHCP Management, LLC, Longwood Capital Partners LLC, GREAT POINT PARTNERS LLC, Visium Asset Management, LP, Rock Springs Capital Management LP, and Sectoral Asset Management Inc. This page lists 32 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

Q2 2015 holders

Holder diff

-3

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.